Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial

Go back to Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial
(NASDAQ: PXS) Delayed: 4.53 --0 (-0%)
Previous Close $4.53    52 Week High $4.27 
Open $4.53    52 Week Low $0.55 
Day High $4.53    P/E N/A 
Day Low $4.53    EPS $0.00 
Volume